Dividend - Normal or Special

[DPHARMA] Final Dividend (with Dividend Re-Investment Plan) on 26-Jun-2019

Announcement Date: 13-Jun-2019
Related Stock:
DPHARMA
DUOPHARMA BIOTECH BERHAD
Share Registrar:
DPHARMA
DUOPHARMA BIOTECH BERHAD
FY: 31-Dec-2018
Amount

RM 0.04

  • Ex Date
    26-Jun-2019
  • Entitlement Date
    27-Jun-2019
  • Payment Date
    26-Jul-2019
Description
DUOPHARMA BIOTECH BERHAD announced a quarterly dividend of RM 0.04 per share. The dividend is payable on 26-Jul-2019, while the ex-date will be on 26-Jun-2019. This is higher than the previous dividend of RM 0.015 per share, with ex-date of 02-Nov-2018 and paid to the shareholders on 23-Nov-2018.

Ann. Date Ex Date Amount Payment Date

About DUOPHARMA BIOTECH BERHAD
Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.

How to be entitled
To be entitled for any of the above, you need to purchase the shares one trading day before the ex-Date. You will not be entitled for the above if you purchase the shares on or after the ex-Date.

On ex-Date, the price will be adjusted to reflect the theoretical market price of the stock after the entitlement. You can sell the shares on / after ex-Date and still be entitled to the corporate exercise. The key is to purchase the shares before ex-Date.

How to apply
No application is needed. Shareholders that fulfill the requirement above will receive the dividend in their registered bank account on the payment date automatically.

Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment